10 Tips To Know About ADHD Medication Pregnancy > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during pregnancy and breastfeeding is a difficult decision for women suffering from the condition. Little data exists about how long-term exposure to these medications could affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological conditions like hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality research is needed.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the advantages of taking them against potential risks to the foetus. Physicians don't have the data to make unambiguous recommendations, but can provide information about risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during early pregnancy did not face a significantly higher risk of fetal cardiac malformations or major structural birth defects. Researchers used a large population-based study of case control to examine the prevalence of major structural defects in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to confirm that the classification was accurate and to reduce any bias.

The study conducted by the researchers was not without limitations. Most important, they were not able to differentiate the effects of the medication from the disorder that is underlying. This limitation makes it difficult to determine whether the small associations observed in the exposed groups are due to medication use or the confounding effect of comorbidities. Additionally the researchers did not look at long-term offspring outcomes.

The study did find that infants whose mothers had taken ADHD medications during pregnancy were at a greater risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or had taken off their medication prior to or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These risks did not seem to be influenced by the kind of medication used during pregnancy.

The research suggests that the low risk associated with the use of strongest adhd medication medications during the early stages of pregnancy may be offset by the greater benefit for both mother and child from continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, if possible, help them develop strategies to improve coping skills that can lessen the negative impact of her condition on her daily functioning and relationships.

Medication Interactions

Doctors are increasingly faced with the decision of whether to keep treatment or stop it during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are taken in the absence of clear and authoritative evidence in either case, which means that doctors must weigh their knowledge from their own experiences, those of other doctors, and what research suggests on the subject and their own best judgment for each patient.

Particularly, the subject of possible risks to the infant can be difficult. The research on this issue is based on observations rather than controlled studies and many of the findings are contradictory. Additionally, the majority of studies limit their analysis to live births, which could underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study presented in the journal club addresses these issues by analyzing both information on deceased and live births.

The conclusion: While some studies have shown that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have not found any evidence of a link, and most studies demonstrate a neutral or slight negative effect. Therefore, a careful risk/benefit assessment must be done in each instance.

For many women with ADHD and ADD, the decision to stop medication is difficult if not impossible. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medications; https://www.youtube.com/, during pregnancy can lead to depression and feelings of isolation. A decrease in medication could also affect the ability to drive safely and perform work-related tasks, which are crucial aspects of normal life for people with ADHD.

She recommends women who are uncertain about whether to continue or stop taking medication because of their pregnancy consider the possibility of educating friends, family members and colleagues on the condition, its impact on daily life, and the advantages of continuing the current treatment regimen. It can also help women feel more confident in her decision. It is important to remember that some drugs can be absorbed through the placenta so if a woman decides to stop taking her common adhd medications medication during pregnancy and breastfeeding, she should be aware that the effects of the drug could be passed on to the baby.

Birth Defects and Risk of

As the use and abuse of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD), increases as does the concern about the potential adverse effects of the drugs on fetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. Researchers used two huge data sets to examine more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. While the overall risk is low, the researchers found that exposure in the first trimester to ADHD medicines was associated with a slightly higher rate of certain heart defects, such as ventriculo-septal defect (VSD).

The researchers of the study found no association between the use of early medications and other congenital anomalies, like facial clefting, or club foot. The results are in line with previous studies showing the presence of a small, but significant increase in the risk of cardiac malformations among women who began taking ADHD medications prior to the time of the time of pregnancy. The risk grew in the latter half of pregnancy, when many women begin to discontinue their ADHD medications.

Women who took ADHD medication in the first trimester were more likely require a caesarean birth and also have a low Apgar after birth and have a baby that needed breathing assistance when they were born. However the authors of the study were unable to eliminate bias due to selection by limiting the study to women who did not have any other medical issues that could have contributed to the findings.

Researchers hope that their study will provide doctors with information when they see pregnant women. They suggest that although discussing the risks and benefits is crucial however, the decision to stop or continue treatment must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also caution that even though stopping the medication is an option, it is not an option to consider due to the high prevalence of depression and other mental health issues among women who are pregnant or recently postpartum. Further, research shows that women who stop taking their medications will have a tough adjustment to life without them once the baby is born.

Nursing

The responsibilities of a new mom can be overwhelming. Women who suffer from ADHD may face a lot of challenges when they must deal with their symptoms, go to doctor appointments and prepare for the birth of a baby and adjust to a new routine. Therefore, many women choose to continue taking their adhd medication how does it work medications throughout pregnancy.

The risk to breastfeeding infant is not too high since the majority of stimulant medication is absorbed through breast milk at a low level. However, the rate of medication exposure to the infant can differ based on the dosage, frequency it is administered and ADHD medications the time of the day it is administered. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk, and the effect of this on a newborn is not well known.

Some doctors may stop taking stimulant medication during a woman's pregnancy due to the absence of research. This is a complicated decision for the patient, who must weigh the benefits of continuing her medication against the possible dangers to the fetus. In the meantime, until more information is available, GPs may ask pregnant patients whether they have an history of ADHD or if they intend to take medication in the perinatal period.

A growing number of studies have proven that women can continue their ADHD medication during pregnancy and while breastfeeding. In response, an increasing number of patients are choosing to do so. They have discovered, in consultation with their physicians that the benefits of retaining their current medication far outweigh any potential risks.

Women who suffer from ADHD who are planning to nurse should seek the advice of an expert psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the pros and cons of continued treatment, including non-pharmacological management strategies. Psychoeducation is also necessary to help pregnant women with ADHD be aware of the symptoms and the underlying disorder. They should also learn about treatment options and build the coping mechanisms. This should include a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include the discussion of a plan for management for both the mother as well as the child, as well as monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.